Zhenling Ji

Zhenling Ji


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ZZZhigang Zhang
Zhigang Zhang
LZLong Zhu
Long Zhu
WHWanjun Hu
Wanjun Hu
JDJidong Dai
Jidong Dai
PRPengfei Ren
Pengfei Ren
ZJZhenling Ji
Zhenling Ji

1 August 2023 in Cancer Biotherapy and Radiopharmaceuticals
Verified
Journal Article
Closed access
ZZZhigang Zhang
Zhigang Zhang
GWGuoqing Wang
Guoqing Wang
XSXiangyu Shao
Xiangyu Shao
HWHailu Wu
Hailu Wu
XSXiangyu Su
Xiangyu Su
ZJZhenling Ji
Zhenling Ji
Objective: To investigate the immunotherapeutic roles and functions of C-C Motif Chemokine Receptor 8 (CCR8) molecule in gastric cancer (GC). Materials and Methods: Clinicopathological features of 95 GC cases were collected by a follow-up survey. The expression level of CCR8 was measured by immunohistochemistry (IHC) staining and analyzed with the cancer genome atlas database. The relationship between CCR8 expression and Clinicopathological features of GC cases was evaluated by univariate and multivariate analysis. Flow cytometry was used to determine the expression of cytokines and the proliferation of CD4+ regulator T cells (Tregs) and CD8+ T cells. Results: An upregulated expression of CCR8 in GC tissues was associated with tumor grade, nodal metastasis, and overall survival (OS). Tumor-infiltrated Tregs with higher expression of CCR8 produced more IL10 molecules in vitro. In addition, anti-CCR8 blocking downregulated IL10 expression produced by CD4+ Tregs, and reversed the suppression by Tregs on the secretion and proliferation of CD8+ T cells. Conclusion: CCR8 molecule could be a prognostic biomarker for GC cases and a therapeutic target for immune treatments.

1 April 2023
Verified
Journal Article
Closed access
ZZZhigang Zhang
Zhigang Zhang
XSXiangyu Shao
Xiangyu Shao
HWHailu Wu
Hailu Wu
XSXiangyu Su
Xiangyu Su
GWGuoqing Wang
Guoqing Wang
ZJZhenling Ji
Zhenling Ji